These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17561390)

  • 21. Short tandem repeat polymorphism and cancer risk: influence of laboratory analysis on epidemiologic findings.
    Tran N; Bharaj BS; Diamandis EP; Smith M; Li BD; Yu H
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2133-40. PubMed ID: 15598771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project.
    Cleveland RJ; Gammon MD; Edmiston SN; Teitelbaum SL; Britton JA; Terry MB; Eng SM; Neugut AI; Santella RM; Conway K
    Carcinogenesis; 2006 Apr; 27(4):758-65. PubMed ID: 16332723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers.
    Huang CS; Kuo SH; Lien HC; Yang SY; You SL; Shen CY; Lin CH; Lu YS; Chang KJ
    Oncologist; 2008 Jul; 13(7):751-60. PubMed ID: 18614591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Family-based genetic association study of insulin-like growth factor I microsatellite markers and premenopausal breast cancer risk.
    Fehringer G; Boyd NF; Knight JA; Paterson AD; Dite GS; Giles GG; Southey MC; Andrulis IL; Hopper JL; Ozcelik H
    Breast Cancer Res Treat; 2009 Nov; 118(2):415-24. PubMed ID: 19229608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HER-2/neu Ile655Val polymorphism and the risk of breast cancer.
    Siddig A; Mohamed AO; Kamal H; Awad S; Hassan AH; Zilahi E; Al-Haj M; Bernsen R; Adem A
    Ann N Y Acad Sci; 2008 Sep; 1138():84-94. PubMed ID: 18837888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of CA repeat polymorphism at intron 1 of insulin-like growth factor (IGF-I) gene with circulating IGF-I concentration, growth, and fatness in swine.
    Estany J; Tor M; Villalba D; Bosch L; Gallardo D; Jiménez N; Altet L; Noguera JL; Reixach J; Amills M; Sánchez A
    Physiol Genomics; 2007 Oct; 31(2):236-43. PubMed ID: 17579179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-like growth factor I (CA) repeats are associated with higher melanoma's Breslow index but not associated with the presence of the melanoma. A pilot study.
    Santonocito C; Paradisi A; Capizzi R; Concolino P; Lavieri MM; Lanza Silveri S; De Luca D; Catricalà C; Di Carlo A; Zuppi C; Ameglio F; Capoluongo E
    Clin Chim Acta; 2008 Apr; 390(1-2):104-9. PubMed ID: 18237549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human epithelial growth factor receptor 2[Ile655Val] polymorphism and risk of breast fibroadenoma.
    Zubor P; Kajo K; Stanclova A; Szunyogh N; Galo S; Dussan CA; Minarik G; Visnovsky J; Danko J
    Eur J Cancer Prev; 2008 Feb; 17(1):33-8. PubMed ID: 18090908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms of glutathione S-transferase A1 and O1 and breast cancer among postmenopausal Danish women.
    Olsen A; Autrup H; Sørensen M; Overvad K; Tjønneland A
    Eur J Cancer Prev; 2008 Jun; 17(3):225-9. PubMed ID: 18414193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential clinical applications of insulin-like growth factor-1 ligand in human breast cancer.
    Chong YM; Subramanian A; Sharma AK; Mokbel K
    Anticancer Res; 2007; 27(3B):1617-24. PubMed ID: 17595785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer.
    Missmer SA; Haiman CA; Hunter DJ; Willett WC; Colditz GA; Speizer FE; Pollak MN; Hankinson SE
    Int J Cancer; 2002 Jul; 100(3):332-6. PubMed ID: 12115549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Body mass index and mortality among older breast cancer survivors in the Study of Osteoporotic Fractures.
    Reeves KW; Faulkner K; Modugno F; Hillier TA; Bauer DC; Ensrud KE; Cauley JA;
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1468-73. PubMed ID: 17627012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women.
    Serin IS; Tanriverdi F; Yilmaz MO; Ozcelik B; Unluhizarci K
    Gynecol Endocrinol; 2008 Mar; 24(3):117-21. PubMed ID: 18335323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulfotransferase1A1 and risk of postmenopausal breast cancer.
    Jerevall PL; Ahmadi A; Bergman M; Stål O; Wingren S
    Anticancer Res; 2005; 25(3c):2515-7. PubMed ID: 16080486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
    Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
    J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of insulin-like growth factor-I and insulin resistance-related genetic variants with lifestyle factors on postmenopausal breast cancer risk.
    Jung SY; Ho G; Rohan T; Strickler H; Bea J; Papp J; Sobel E; Zhang ZF; Crandall C
    Breast Cancer Res Treat; 2017 Jul; 164(2):475-495. PubMed ID: 28478612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis.
    Pasanisi P; Venturelli E; Morelli D; Fontana L; Secreto G; Berrino F
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1719-22. PubMed ID: 18628423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HER2 codon 655 polymorphism and breast cancer risk: a meta-analysis.
    Tao W; Wang C; Han R; Jiang H
    Breast Cancer Res Treat; 2009 Mar; 114(2):371-6. PubMed ID: 18438707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One-carbon metabolism-related gene polymorphisms and risk of breast cancer.
    Suzuki T; Matsuo K; Hirose K; Hiraki A; Kawase T; Watanabe M; Yamashita T; Iwata H; Tajima K
    Carcinogenesis; 2008 Feb; 29(2):356-62. PubMed ID: 18174236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.